Basilea Pharmaceutica Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Basilea Pharmaceutica Limited with three other
miscellaneous service companies in Europe:
sales of 66.79 million Euro [US$75.99 million]
of which 74%
was Partnered Discovery),
Pharming Group NV
of the Netherlands
(89.62 million Euro [US$101.96 million]
of which 100%
was Recombinant Proteins), and
based in Poland
(361.65 million Polish New Zlotys [US$95.95 million]
of which 59%
was Insulin (Bioton SA)).
Basilea Pharmaceutica Limited reported sales of 90.67 million Swiss Francs (US$91.50 million)
December of 2017.
increase of 39.4%
versus 2016, when the company's sales were 65.04 million Swiss Francs.
This was the fourth straight year of sales growth at Basilea Pharmaceutica Limited.